Vanderbilt University/Ingram Cancer Center
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, United States12 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma | B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm, non-Hodgkin lymphoma | Recruiting | Phase 2 | 2026-10-02 | NCT07763210 | |
| The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository | clonal hematopoiesis | Recruiting | Not stated | 2026-09-23 | NCT06701214 | |
| Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-08-19 | NCT06399640 | |
| Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers | Carcinoma, Lobular, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Skin and Connective Tissue Diseases, adenocarcinoma, breast disorder, breast neoplasm, carcinoma, epithelial neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-08-19 | NCT05919108 | |
| Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial | Neoplasms by Site, Thoracic Neoplasms, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not applicable | 2026-08-18 | NCT06593106 | |
| Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Recruiting | Phase 2 | 2026-08-17 | NCT07673367 | |
| Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors | pancreatic neuroendocrine tumor G1 | Recruiting | Phase 4 | 2026-06-24 | NCT06016855 | |
| A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules | Pulmonary Nodule | Active, not recruiting | Not stated | 2026-05-04 | NCT06074133 | |
| Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules | Neoplasms by Site, Thoracic Neoplasms, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not applicable | 2026-03-27 | NCT06638398 | |
| Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 1 | 2025-10-03 | NCT05945875 | |
| Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma | Recruiting | Not stated | 2025-09-19 | NCT06482957 | |
| Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy | Brain Metastases, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, brain disorder, carcinoma, central nervous system cancer, central nervous system disorder, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, nervous system disorder, squamous cell carcinoma | Recruiting | Early phase 1 | 2024-09-23 | NCT05996432 |